Calithera Biosciences Inc...
(CALA)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -39.65M | -115.09M | -90.14M | -89.86M | -54.63M | -27.83M | -38.00M | -32.64M | -21.71M | -12.38M | -7.97M |
| Depreciation & Amortization | 255.00K | 280.00K | 364.00K | 479.00K | 505.00K | 365.00K | 297.00K | 404.00K | 361.00K | 281.00K | 269.00K |
| Stock-Based Compensation | 4.03M | 10.26M | 8.06M | 6.47M | 7.44M | 5.54M | 4.25M | 3.27M | 689.00K | 70.00K | 31.00K |
| Other Working Capital | -4.51M | -5.06M | -3.90M | 289.00K | -22.22M | 31.70M | 1.87M | -1.27M | 886.00K | 59.00K | 653.00K |
| Other Non-Cash Items | -817.00K | 41.65M | 1.51M | 1.37M | -272.00K | 455.00K | 4.84M | 3.72M | 689.00K | 70.00K | 31.00K |
| Deferred Income Tax | n/a | 2.00K | -142.00K | -897.00K | n/a | n/a | -4.25M | -3.28M | -687.00K | -65.00K | -24.00K |
| Change in Working Capital | -7.43M | -3.40M | -3.96M | 3.70M | -17.88M | 35.22M | 1.84M | -1.40M | 1.43M | 184.00K | 678.00K |
| Operating Cash Flow | -43.61M | -66.30M | -84.31M | -78.75M | -64.84M | 13.75M | -31.02M | -29.93M | -19.23M | -11.84M | -6.99M |
| Capital Expenditures | -133.00K | -147.00K | -61.00K | -7.00K | -214.00K | -1.23M | -401.00K | -441.00K | -556.00K | -164.00K | -49.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -23.70M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | -57.06M | -153.23M | -76.11M | -194.65M | -44.62M | -109.10M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 8.00M | 146.08M | 142.45M | 129.12M | 97.45M | 68.72M | 42.76M | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -394.00K | 23.70M | n/a | 70.00K | -9.00K | n/a |
| Investing Cash Flow | -133.00K | 7.85M | 88.96M | -10.78M | 52.80M | -98.83M | 23.70M | -66.78M | -486.00K | -173.00K | -49.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 16.00K | 4.00K | 1.20M | 1.22M | 921.00K | 1.33M | 535.00K | 845.00K | 16.24M | 43.56M | 5.97M |
| Financial Cash Flow | 9.65M | 10.67M | 42.06M | 98.91M | 14.63M | 122.95M | 11.82M | 845.00K | 87.87M | 43.63M | 5.97M |
| Net Cash Flow | -34.09M | -47.78M | 46.71M | 9.38M | 2.58M | 37.87M | 4.50M | -95.86M | 68.15M | 31.61M | -1.07M |
| Free Cash Flow | -43.74M | -66.45M | -84.37M | -78.75M | -65.06M | 12.52M | -31.43M | -30.37M | -19.79M | -12.00M | -7.04M |